Skip to main content
OpenTrials
Completed

NCT Number: NCT02776189

Dexmedetomidine Verses Propofol for Paediatric MRI Brain

MRI though not painful requires deep sedation for children due to the loud noise created. With deep sedation comes respiratory depression so the interest in Dexmedetomidine. For standardization MRI brain was chosen and also for the fact that patients usually have history of convulsions where drugs like ketamine may not be a good option. Patients were recruited after ethics committee approval. After pre-medication with intranasal midazolam 0.2 mg/kg body weight, Intravenous access was established and then patients were divided in two groups. One group received intravenous propofol 2mg/Kg and infusion of 100mcg/per kg body weight per minute. The other group received intravenous bolus of Dexmedetomidine 1mcg/kg over 10 minutes and then a infusion of Dexmedetomidine 1mcg/kg/hour.

Primary out come was to study the recovery time of patients sedated with Dexmedetomidine compared to patients sedated with propofol for paediatric MRI brain. Secondary outcome were analysed in terms of time for induction,procedural disruptions due to awakening and haemodynamic stability . Follow up was done on phone for any adverse events.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Brain Diseases Central Nervous System Diseases Nervous System Diseases

Age range

1 year–7 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Lokmanya Tilak Municipal General Hospital and Lokmanya Tilak Municipal Medical College

Mumbai, Maharashtra, 400022, India

About this study

Patients were evaluated on out patient department basis. On the day of MRI nil per oral status of 6 hours was confirmed and consent taken from the parent. In recovery room after recording of vitals, children were given intranasal midazolam 0.2mg/kg body weight. The intravenous line was secured after the child was sedated. Patients were then divided in two groups. In the MRI console, the dexmedetomidine group received intravenous dexmedetomidine 1mcg/kg body weight over 10 minutes. An intravenous infusion of dexmedetomidine was then started at 1mcg/kg/hour.

The propofol group received 2mg /kg of intravenous propofol and an infusion of 100mcg/kg/minute.

MRI monitoring included pulseoximetry, cardioscope, respiratory pattern and rate. Oxygen was delivered by nasal prongs. Primary outcome measured was the time for recovery.

Secondary outcomes were number of awakening during procedure, haemodynamic stability, induction time and any adverse events.

After MRI the children were observed in the recovery room and discharged after achieving 'modified aldred score' of 10. Vitals and any adverse events were recorded during this phase.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • children posted for elective MRI brain
  • American society of anaesthesiologist physical status I and II

Exclusion criteria

  • age less than 1 year and more than 7 years
  • American society of anaesthesiologist physical status III and IV
  • emergency cases
  • upper respiratory tract infection
  • patients on digoxin and beta blockers
  • allergy to study drugs
  • Body mass index more than 35

Treatment and study plan

Dexmedetomidine

Drug

intravenous dexmedetomidine 1 mcg per kg body weight over 10 minutes followed by infusion of dexmedetomidine at dose of 1 mcg per kg body weight per hour till end of procedure

Other names: Dexem

Propofol

Drug

intravenous propofol 2mg per kg body weight followed by infusion of propofol at a dose of 100 mcg per kg body weight per min till end of procedure

Other names: propoven, diprivan

midazolam

Drug

Intra nasal midazolam 0.2 mg per kg body weight before intravenous canulation

Other names: Versed, Fulsed

Primary outcomes

  1. Recovery time

    Time frame: 4 hours after procedure

    Recovery time - time from the end of the procedure till the patient achieves a Modified aldred score of 10.Modified Aldred Score- a score from 0- 10 considering 5 parameters of activity, oxygen saturation, respiration, circulation and consciousness each given score 0,1,2. Score of 10 patients can be sent home after outpatient anaesthesia.

Secondary outcomes

  1. Time for induction

    Time frame: One hour

    time for induction - time from administration of drug to the patient till the patient is sedated enough for allowing positioning for MRI

  2. Procedural disruptions due to awakening of the patient

    Time frame: one hour

    Number of patients in each group who had one or more awakening during the procedure was compared

  3. Bradycardia

    Time frame: 6 hours

    number of patients having bradycardia after induction till recovery was compared. Bradycardia is heart rate less than 60 beats per minute

  4. Desaturation

    Time frame: 6 hours

    Number of patients in each group that had desaturation was compared. Desaturation was defined as drop in oxygen saturation of less than 98 percent inspite of supplemented oxygen. Normal oxygen saturation as measured by pulse oximeter is 100 percent on room air.

Sponsors and collaborators

Lead sponsor

Maharashtra University of Health Sciences

Other

Registry information

Official study title

Comparative Study of Dexmedetomidine-midazolam Combination and Propofol-midazolam Combination for MRI Brain in Paediatric Patient

Acronym: DPMP

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
May 18, 2016
Registry last updated
Jul 19, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.